Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations. If you cannot find what you are looking for, do not hesitate to get in touch with us.
Oncopeptides AB (publ) released its interim report for Q3 2020 on November 19, 2020.
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com